Pulmonary Arterial Hypertension with Features of Venous Involvement: A Detective's Task.
Daniel Inácio CazeiroRui PlácidoMiguel Azeredo RaposoJoana BritoAlexandra BorbaTatiana GuimarãesEugénia PintoPedro FreitasFausto J PintoPublished in: Arquivos brasileiros de cardiologia (2024)
Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis are rare types of histopathological substrates within the spectrum of pulmonary arterial hypertension (PAH) with a very poor prognosis. They are characterized by a widespread fibroproliferative process of the small caliber veins and/or capillaries with sparing of the larger veins, resulting in a pre-capillary pulmonary hypertension phenotype. Clinical presentation is unspecific and similar to other PAH etiologies. Definitive diagnosis is obtained through histological analysis, although lung biopsy is not advised due to a higher risk of complications. However, some additional findings may allow a presumptive clinical diagnosis of PVOD, particularly a history of smoking, chemotherapy drug use, exposure to organic solvents (particularly trichloroethylene), low diffusing capacity for carbon monoxide (DLCO), exercise induced desaturation, and evidence of venous congestion without left heart disease on imaging, manifested by a classical triad of ground glass opacities, septal lines, and lymphadenopathies. Lung transplant is the only effective treatment, and patients should be referred at the time of diagnosis due to the rapid progression of the disease and associated poor prognosis. We present a case of a 58-year-old man with PAH with features of venous/capillary involvement in which clinical suspicion, prompt diagnosis, and early referral for lung transplantation were determinant factors for the successful outcome.
Keyphrases
- pulmonary hypertension
- pulmonary arterial hypertension
- poor prognosis
- pulmonary artery
- long non coding rna
- ejection fraction
- newly diagnosed
- primary care
- high resolution
- squamous cell carcinoma
- prognostic factors
- locally advanced
- radiation therapy
- risk factors
- polycyclic aromatic hydrocarbons
- mass spectrometry
- inferior vena cava
- photodynamic therapy
- smoking cessation
- atrial fibrillation
- minimally invasive
- left ventricular
- data analysis